SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-037687
Filing Date
2022-02-14
Accepted
2022-02-11 20:35:53
Documents
2
Group Members
SIMEON GEORGESR ONE CAPITAL FUND I AGGREGATOR, LPSR ONE CAPITAL PARTNERS I, LPSR ONE CO-INVEST I, LLCSR ONE CO-INVEST MANAGER I, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d307822dsc13g.htm SC 13G 112609
2 EX-99.1 d307822dex991.htm EX-99.1 10004
  Complete submission text file 0001193125-22-037687.txt   124441
Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Subject) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91982 | Film No.: 22624089
SIC: 2834 Pharmaceutical Preparations

Mailing Address 985 OLD EAGLE SCHOOL ROAD SUITE 511 WAYNE PA 19087
Business Address 985 OLD EAGLE SCHOOL ROAD SUITE 511 WAYNE PA 19087 (610) 766-2240
SR ONE CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001853723 (see all company filings)

IRS No.: 843383413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G